Home Newsfeeds SVB Leerink Maintains Underperform on AbbVie, Lowers Price Target to $135

SVB Leerink Maintains Underperform on AbbVie, Lowers Price Target to $135

SVB Leerink analyst David Risinger maintains AbbVie (NYSE:ABBV) with a Underperform and lowers the price target from $140 to $135.

byBenzinga Newsdesk

September 30, 2022

1 minute read

SVB Leerink analyst David Risinger maintains AbbVie (NYSE:ABBV) with a Underperform and lowers the price target from $140 to $135.

Canaccord Genuity Maintains Buy on Pacific Biosciences, Raises Price Target to $14

By Benzinga Newsdesk

November 16, 10:16 AM

Canaccord Genuity analyst Kyle Mikson maintains Pacific Biosciences (NASDAQ:PACB) with a Buy and raises the price target from $12 to $14.

PACB

Global
News

‘China Expands iPhone Ban To Local Governments, State-Owned Firms’ – Nikkei Asia

By Benzinga Newsdesk

December 15, 5:03 PM

https://asia.nikkei.com/Politics/International-relations/US-China-tensions/China-expands-iPhone-ban-to-local-governments-state-owned-firms#:~:text=GUANGZHOU%20%2D%2D%20China's%20restrictions%20on,official%20business%20since%20around%202020.

AAPL

EF Hutton Maintains Buy on IDW Media Holdings, Lowers Price Target to $2

By Benzinga Newsdesk

January 20, 8:03 AM

EF Hutton analyst Edward Reilly maintains IDW Media Holdings (AMEX:IDW) with a Buy and lowers the price target from $3 to $2.

IDW

CACI Announced $750M Share Repurchase Authorization

By Charles Gross

January 26, 7:06 AM

CACI International Inc (NYSE: CACI) announced today that its Board of Directors has authorized the repurchase of up to $750 million of its common stock.

CACI

SVB Leerink Maintains Underperform on AbbVie, Lowers Price Target to $135

Related Posts

Canaccord Genuity Maintains Buy on Pacific Biosciences, Raises Price Target to $14

‘China Expands iPhone Ban To Local Governments, State-Owned Firms’ – Nikkei Asia

EF Hutton Maintains Buy on IDW Media Holdings, Lowers Price Target to $2

CACI Announced $750M Share Repurchase Authorization